| Price | 2.12 |
| Price Change Today | 0.00 (0.00%) |
| P&P rating | ![]() |
| Zacks Rank | 2 - BUY |
| Open Price | $0.00 |
| Previous Close | $2.12 |
| Daily Range | $0.00 - $0.00 |
| 52-Week Range | $0.77 - $4.05 |
| Volume | 0 |
| BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any process, substance, or combination thereof, that delivers drugs into the body. | |




Comments: 0 | Comment
The fact that the FDA informed Biodelivery that a decision is close and an extension letter would not be needed is a positive sign, in my opinion. With the BDSI stock price slowly inching up over the past few months chances of an Onsolis approval are good.
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment